Walgreens Boots Alliance (NASDAQ:WBA) had its price target reduced by Morgan Stanley from $61.00 to $58.00 in a research note issued to investors on Friday morning, AnalystRatings.com reports. Morgan Stanley currently has an equal weight rating on the pharmacy operator’s stock.

WBA has been the subject of several other reports. JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an overweight rating for the company in a research note on Friday, June 28th. ValuEngine raised Walgreens Boots Alliance from a strong sell rating to a sell rating in a research note on Friday, June 28th. Bank of America decreased their price objective on Walgreens Boots Alliance from $53.00 to $51.00 and set an underperform rating for the company in a research note on Monday, June 3rd. Zacks Investment Research cut Walgreens Boots Alliance from a hold rating to a sell rating and set a $53.00 price objective for the company. in a research note on Monday, June 10th. Finally, BidaskClub cut Walgreens Boots Alliance from a sell rating to a strong sell rating in a research note on Monday, June 24th. Six equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. The company has an average rating of Hold and an average price target of $63.65.

NASDAQ WBA opened at $49.32 on Friday. The stock has a fifty day moving average of $53.61 and a 200-day moving average of $57.04. The stock has a market capitalization of $46.02 billion, a P/E ratio of 8.19, a price-to-earnings-growth ratio of 1.27 and a beta of 0.81. Walgreens Boots Alliance has a 52 week low of $49.12 and a 52 week high of $86.31. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.37 and a current ratio of 0.76.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.05. The company had revenue of $34.59 billion during the quarter, compared to analysts’ expectations of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same period last year, the firm earned $1.53 EPS. Equities research analysts forecast that Walgreens Boots Alliance will post 5.99 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be paid a dividend of $0.458 per share. The ex-dividend date of this dividend is Monday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.71%. Walgreens Boots Alliance’s payout ratio is 30.40%.

In related news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the completion of the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 15.73% of the stock is owned by insiders.

Hedge funds have recently bought and sold shares of the business. Comerica Securities Inc. increased its stake in Walgreens Boots Alliance by 23.7% in the fourth quarter. Comerica Securities Inc. now owns 16,457 shares of the pharmacy operator’s stock valued at $1,124,000 after purchasing an additional 3,154 shares during the last quarter. Geode Capital Management LLC increased its stake in Walgreens Boots Alliance by 7.8% in the fourth quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock valued at $786,522,000 after purchasing an additional 834,241 shares during the last quarter. CWM LLC increased its stake in Walgreens Boots Alliance by 9.2% in the first quarter. CWM LLC now owns 6,705 shares of the pharmacy operator’s stock valued at $424,000 after purchasing an additional 566 shares during the last quarter. Mercer Global Advisors Inc. ADV purchased a new position in Walgreens Boots Alliance in the first quarter valued at approximately $8,765,000. Finally, Gilman Hill Asset Management LLC increased its stake in Walgreens Boots Alliance by 16.5% in the first quarter. Gilman Hill Asset Management LLC now owns 6,010 shares of the pharmacy operator’s stock valued at $380,000 after purchasing an additional 850 shares during the last quarter. Hedge funds and other institutional investors own 62.03% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Cost of Capital Explained

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.